available 24/7
available 24/7
partner
The FDA’s withdrawing it approval of Avastin (bevacizumab) to treat breast cancer received major media coverage, including front-page articles in major papers and a lead story on a network newscast. ABC World News (11/18, story 5, 0:35, Muir) reported,
“The FDA revoked its approval” of Avastin “as a treatment for breast cancer saying there’s no evidence it helps patients live longer or better and citing dangerous side effects, despite the pleas of some patients who say the drug saved their lives.”
The FDA’s withdrawing it approval of Avastin (bevacizumab) to treat breast cancer received major media coverage, including front-page articles in major papers and a lead story on a network newscast. ABC World News reported, “The FDA revoked its approval” of Avastin “as a treatment for breast cancer saying there’s no evidence it helps patients live longer or better and citing dangerous side effects, despite the pleas of some patients who say the drug saved their lives.”
If you have become the victim of a dangerous or defective pharmaceutical, you may be eligible for compensation. Contact a personal injury attorney from PKSD today for your free case review.
PKSD – 414-333-3333.
This page has been written, edited, and reviewed by a team of legal writers following our comprehensive editorial guidelines. This page was approved by attorney Jeffery A. Pitman, who has more than 28 years of legal experience and handled thousands of personal injury cases while obtaining millions of dollars in verdicts and settlements in Wisconsin, Illinois, Iowa and New Mexico.
In this month’s edition of the PKSD Newsletter, You Should Know, we cover the opioid epidemic and the lawsuits being filed by state, county...
The following products have been recalled by the FDA for various reasons. For more information, please go to www.fda.gov. Rushing Waters Fisheries, Palmyra, is...
A new report released by the Government Accountability Office (GAO) reveals disturbing gaps in the the Food and Drug Administrations (FDA) tracking of drug...
